Between Mangar and Winncare, the vast majority of our sales are still based in Europe. Our next focus market is absolutely the North American region
In Conversation
Many [biotech] companies are obliged to leave France or be bought out by Big Pharma, making it impossible to create the next big French success story
The big question in AI is how to get data and who the data belongs to
Cellectis is working to develop the concept of off-the-shelf, gene edited UCART cells – universal CAR-T
Today, healthcare is not only shaped by patients and physicians; it is a convergence of different actors which have a major influence on the market
The intent of the government to transform the healthcare system is a step in the right direction. However, there are several problems in the French healthcare…
Today, Canon is acknowledged as a heavyweight imaging player, and not just a niche player in certain areas
Access to healthcare is a critical issue around the world. At Orange Healthcare we believe that digitization is a major part of the solution to this…
The French system today is well positioned to breed many startup companies and can offer plenty of economic help. However, once products obtain their CE mark…
Generics companies need a wide portfolio to meet all of the generics needs of pharmacists and to be competitive
To work with the French people, the authorities, and healthcare professionals, it is absolutely natural and normal to embrace the language and culture
Digital transformation is not about the devices, but it starts with – and all comes down to – the people
